The Johnson & Johnson trial is on pause, and one participant in an AstraZeneca trial has died. Given that millions could be receiving either vaccine, even the slightest complications warrant scrutiny.
The Johnson & Johnson trial is on pause, and one participant in an AstraZeneca trial has died. Given that millions could be receiving either vaccine, even the slightest complications warrant scrutiny.